Gold Mountain (ASX:GMN): Achieves further exploration success
Gold Mountain (ASX:GMN) has received a batch of 54 stream sediment samples from the Irajuba tenements in the Down Under Project area in Brazil 🪨 Very high grade results in stream sediment samples demonstrate 👉 Jiquiriçá tenements in Down Under have excellent REE potential. ASX announcement: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02836200-2A1539635&v=fc9bdb61fe50ea61f8225e24ce041a0e155a9400
What’s Hot – BPH, HCL, CTM, LBT, HCH, AW1, AWJ & PSC
What’s Hot, Not & Doing Brought to you by TSN Contributor & Wealth Advisor Nick Kelso What’s Hot – BPH, HCL, CTM, LBT, HCH, AW1, AWJ & PSC What’s Not – CAZ & MOZ What’s Hot BPH – BPH Energy Limited today closed up 38% to finish at 2.2c on $1.3m stock traded. The reason […]
Nyrada Inc. (ASX:NYR): Developing NYR-BI03
Nyrada Inc. (ASX:NYR) has made progress on developing NYR-BI03, a first in class neuroprotection treatment for both traumatic brain injury (TBI) and stroke. – Additional study provided further data to support safety and tolerability of Nyrada’s lead Brain Injury drug candidate. – Rat CNS testing satisfactorily completed under Good Laboratory Practice (GLP) conditions for NYR-BI03. […]
LTR Pharma (ASX:LTP) indicates first patients have received SPONTAN® under TGA Scheme
LTR Pharma (ASX:LTP) has announced that the first patients have received SPONTAN®, a nasal spray treatment for erectile dysfunction (ED), under the Therapeutic Goods Administration (TGA) Special Access Scheme. First patients receive SPONTAN® under the TGA Special Access Scheme Demonstrates potential for SPONTAN® in an unmet fast-acting, on-demand erectile dysfunction treatment market Internationally recognised Key […]
Short Video: Tryptamine Therapeutics (ASX:TYP): Clinical-stage biotech focused on psychedelic drug development
Tryptamine Therapeutics Limited (ASX:TYP) is a clinical-stage biotech and its current primary focus is the development of an innovative and scalable intravenous-infused psilocin formulation which can be used in conjunction with psychotherapy to address significant unmet medical needs. Tryptamine Therapeutics CEO and Executive Director Jason Carroll speaks with The Stock Network’s Lel Smits. 🧬 Phase […]
AML3D (ASX:AL3): Announces Arcemy® ‘X-Edition’ Commissioned at US Navy supplier cogitic corp
AML3D (ASX:AL3) announces Arcemy® ‘X-Edition’ Commissioned at US Navy supplier cogitic corp ➡️ The A$2.5 million ARCEMY® ‘X-Edition 6700’ ordered by US Defence contractor, Cogitic Corporation, is now commissioned and operational. ➡️ Cogitic is positioned to supply ARCEMY® metal 3D printed’, ‘cannot fail’, components to the US Navy and other defence applications. ASX Announcement: https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02835365-6A1219268&v=70bc033a22188bdfefb8a0b8ad3c24897ef2837d
Western Gold Resources (ASX: WGR): Completes a mining-level Aboriginal heritage survey
Western Gold Resources (ASX: WGR) has completed a mining-level Aboriginal heritage survey at the Company’s 100% owned Gold Duke Project in the north-eastern goldfields of Western Australia. – Aboriginal heritage clearance secured – Additional surveys planned for Q3 to expand gold production – Scoping study underway to determine best processing method for 4.57Mt gold resource […]
Tryptamine Therapeutics (ASX:TYP): Clinical-stage biotech focused on psychedelic drug development
Tryptamine Therapeutics Limited (ASX:TYP) is a clinical-stage biotech and its current primary focus is the development of an innovative and scalable intravenous-infused psilocin formulation which can be used in conjunction with psychotherapy to address significant unmet medical needs. The Company’s Phase 2a clinical trial investigating the treatment of Irritable Bowel Syndrome (‘IBS’) is now underway […]
What’s Hot – EEL, BEZ, AMS, KAI, AMD, LRV & LAT
What’s Hot, Not & Doing Brought to you by TSN Contributor & Wealth Advisor Nick Kelso What’s Hot – EEL, BEZ, AMS, KAI, AMD, LRV & LAT What’s Not – DRO What’s Hot EEL – ENRG Elements Limited today closed up 50% to finish at 0.3c on $400k stock traded. The reason they were up […]
Globe Metals & Mining (ASX:GBE): Releases Quarterly Report June 2024
Globe Metals & Mining (ASX:GBE) has released its Quarterly Activities Report – June 2024 Quarter. 🌏 Funding update confirms the Phase 1 development plan for Globe’s Malawi-based Kanyika Niobium Project and provides a clear path to its construction 🌏 Globe received a non-binding letter of intent from Ecobank Malawi Limited to provide the Company with […]